- Docket No.
- 1:26-cv-01190
- District Court
- District of Columbia
Goal
- Block enforcement of an agency action
- Declaration that agency action is unlawful
- Vacate agency action
Issues
Litigation Content
Why This Matters:
Why This Matters:
The plaintiff, a drug manufacturer, challenges the Health Resources and Services Administrations’ (HRSA) oversight over the 340B drug discount program, which requires drug manufacturers to sell certain safety-net providers outpatient drugs at a discount. Federal law prohibits such providers from selling or transferring the discounted drug to a person who is not a patient of the provider. HRSA’s guidelines implementing the 340B program define who qualifies as a “patient,” but the plaintiff argues that the definition is overly broad and inconsistent with the 340B statute.
Potential Impact:
Potential Impact:
A ruling in favor of the plaintiff would constrain HRSA’s interpretive authority under the 340B statute.
10 Major Filings
- AMICUS BRIEF [AMERICAN HOSPITAL ASSOCIATION ET AL.] (Jul 14, 2026)
- PROPOSED INTERVENORS NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS ET AL.'S MOTION TO INTERVENE (Jul 7, 2026)
- SCHEDULING ORDER (Jun 30, 2026)
- PROPOSED INTERVENOR 340B HEALTH ET AL.'S RESPONSE TO MOTION FOR EXTENSION OF TIME (Jun 26, 2026)
- PLAINTIFF'S MOTION FOR EXTENSION OF TIME (Jun 25, 2026)
- PROPOSED INTERVENOR 340B HEALTH ET AL.'S MOTION TO INTERVENE (Jun 23, 2026)
- SCHEDULING ORDER (Jun 22, 2026)
- DEFENDANTS' MOTION TO DISMISS (Jun 16, 2026)
- SCHEDULING ORDER (Jun 12, 2026)
- COMPLAINT (Apr 8, 2026)